Clinical trial
Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally…
NCT00238407 · Swiss Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00238407 |
|---|---|
| Title | Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery |
| Official title | Docetaxel and Cisplatin Chemotherapy Followed by Radiochemotherapy in Patients With Inoperable, Locally Advanced Esophageal Cancer, A Multicenter Phase II Trial |
| Lead sponsor | Swiss Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Docetaxel and Cisplatin, Radiotherapy |
| Enrollment | 21 |
| Start date | Mar 1, 2004 |
| Primary completion | Feb 1, 2008 |
| Completion | Aug 1, 2010 |
| First posted | Oct 13, 2005 |
| Last update posted | Jun 5, 2012 |
| Countries | Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: